Please help the GEDSA ENFit clinical advisory board assess conversion status by completing the following quick survey

https://forms.office.com/Pages/ResponsePage.aspx?id=WGRxUhS5HU61dYwQBPPs...

How does your institution calculate IBW for patients less than 5 feet tall?
How does your institution calculate IBW for patients with amputations
What formula do you currently use (growth charts, Traub formula, etc.)?

Interested in how other institutions have built their sterile water 10ml order sentences to reflect that it is for diluent use only. What route have you used in the orderable? I am thinking that we may need to build a new route of "diluent", "other" or "misc" for safety purposes to reflect that the SW itself should not be given IV Push without using as a diluent first. Appreciate any feedback.

Heather

Good afternoon,
Our pediatric outpatient dialysis centers see both children and young adults and have changed practices several times over the years in regards to lock solutions for their hemodialysis catheters. Currently they are using alteplase to each lumen at each session. I wanted to poll the group on the following:
1. What population(s) is/are seen in your outpatient dialysis center(s)?
2. What is the standard lock solution used for hemodialysis catheters?
3. If heparin, what concentration are you utilizing?

Good afternoon,
I am wondering if you can share your thoughts on this Joint Commission requirement: "Medications are dispensed in the most ready-to-administer forms commercially available and, if feasible, in unit doses that have been repackaged by the pharmacy or licensed repackager."

Hi All,

Can those of you who work at health-systems with multiple inpatient sites on one instance of Epic share your approach to High Alert medications? Specifically,

1) Do you have one shared list or does each site have their own?
2) Do you leverage your EMR-generated labels to designate those meds that are High Alert? How does this work if you have one list?

Adult Medical Emergency pharmacists at YNHH are going to start a pilot to bring tenecteplase kits to codes soon. They will obtain the drug kit at the beginning of their shift and if not used return it to inventory by the end of their shifts

How are other organizations supporting the carrying of medications on personnel so that one is maintaining drug security, but also ensuring maintenance of proper storage conditions? In other words, how have you addressed the concern for lab coat pocket or fanny pack use and adjacent body temperature?

Our institution is looking to develop a process for regularly reviewing agents for vesicant or irritant potential when it is 1) FDA approved and 2) reported to FDA post market as having vesicant/irritant potential. Does your hospital have a committee or task force that manages/reviews this? Are there any specific resources that you use when reviewing this information? Any other information you can provide about your process would be greatly appreciated. Thank you!

Hi,
Our organization is going through an analysis of independent double checks to make sure they are judiciously used. I had a couple questions for the group:

1. What are the objective criteria you use to determine if a medication requires IDC at administration?

2. Are there instances when an IDC is performed but not documented?

3. In the meds you require IDC, is there a carve out for in emergent situations "it is not required if delay in care could cause harm to the patient in an emergent situation" (or something similar)?

One of our pharmacists noticed turbidity in a ferrous sulfate solution stock bottle that had been opened less than a month ago. We are unsure if this is due to contamination from mishandling by our staff or if there is a problem with the product itself.

Please share if you have experienced a similar issue.

Product details:
Ferrous sulfate solution
15 mg of elemental iron per ml
Patrin Pharma
NDC: 39328-557-50
Lot: M1054
Exp: 12/24

Thanks,
Perry Shafner
pshafner@gbmc.org